Home › Funds › BRADLEY FOSTER & SARGENT INC/CT › ABBV

BRADLEY FOSTER & SARGENT INC/CT position in ABBV

ABBVIE INC · Health Care

BRADLEY FOSTER & SARGENT INC/CT reported holding 206,294 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$54.0M, representing 0.77% of its reported portfolio and ranking #35 among its reported holdings. BRADLEY FOSTER & SARGENT INC/CT has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)206.29K sh
Reported value held$53.96M
Portfolio Weight0.77%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How BRADLEY FOSTER & SARGENT INC/CT's ABBV position evolved

BRADLEY FOSTER & SARGENT INC/CT first disclosed a stake in ABBV in Q3 2023 at 257,531 shares (US$34.7M). The position peaked in Q2 2026 at 219,509 shares, worth US$55.2M. Across 13 filings, BRADLEY FOSTER & SARGENT INC/CT increased the stake 0 time(s), trimmed it 10 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 206,294 shares valued at US$54.0M — a reduction of -13,215 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 257.53K $34.70M New
Q4 2023 252.28K $39.10M Reduce
Q1 2024 245.53K $44.71M Reduce
Q2 2024 244.31K $41.90M Hold
Q3 2024 238.37K $47.07M Reduce
Q4 2024 235.30K $41.81M Reduce
Q1 2025 232.28K $48.67M Reduce
Q2 2025 232.72K $43.20M Hold
Q3 2025 231.16K $53.52M Reduce
Q4 2025 228.00K $52.10M Reduce
Q1 2026 223.12K $48.53M Reduce
Q2 2026 219.51K $55.24M Reduce
Q3 2026 206.29K $53.96M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 32 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$38.97B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has BRADLEY FOSTER & SARGENT INC/CT held ABBV?

BRADLEY FOSTER & SARGENT INC/CT has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BRADLEY FOSTER & SARGENT INC/CT's current position in ABBV?

As of Q3 2026, BRADLEY FOSTER & SARGENT INC/CT holds 206.29K shares of ABBV (ABBVIE INC), valued at $53.96M, representing 0.77% of its reported portfolio and ranking #35.

Has BRADLEY FOSTER & SARGENT INC/CT been buying or selling ABBV?

In the latest 13F filing (Q3 2026), BRADLEY FOSTER & SARGENT INC/CT reduced its position in ABBV. The position peaked in Q2 2026 at 219.51K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.